Nanalysis Presenting at Upcoming Conferences

Rhea-AI Summary

Nanalysis Scientific Corp. will participate in two upcoming investment conferences. The first is the LD Micro Conference on June 7, 2022, at 4:30 PM ET, where investors can engage in 1x1 meetings. The second event is the OTCQX Best 50 Virtual Investor Conference on June 16, 2022, at 1:00 PM ET, also featuring virtual 1x1 sessions. Nanalysis specializes in portable NMR technology and aims to enhance investor engagement through these interactive presentations.

LD Micro on June 7-8th

2022 OTCQX Best 50 Virtual Investor Conference on June 16th

CALGARY, AB, June 6, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces it will be attending the following upcoming conferences. 

Nanalysis will present to investors at the LD Micro Conference:
Tuesday June 7, 2022 at 4:30pm ET
Additionally, Nanalysis CEO Sean Krakiwsky will be on site for 1x1's on June 7th and 8th.
To access the presentation or schedule a meeting go to:
https://www.meetmax.com/sched/event_82067/__co-list_cp.html 

Nanalysis will present at the 2022 OTCQX Best 50 Virtual Investor Conference:
Thursday June 16, 2022 at 1:00pm ET
Additionally, management will be available for virtual 1x1's that day.
To access the presentation or schedule a meeting use the following link:
https://bit.ly/3MB962u

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check for both conferences to expedite participation and receive event updates.

Learn more about theses events at www.ldmicro.com and www.virtualinvestorconferences.com.

About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)

Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', OTC and the Frankfurt exchange under the ticker symbol '1N1'. The company's business is what we term "MRI and NMR for industry". The company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. Nanalysis recently announced that it has begun selling a 100MHz device in 2020. The Company's new device will be the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.

With the recent acquisition of K'Prime, the company maintains a North American sales and service company of over 40 individuals who cover scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.

Additionally, the Company has a 43% ownership in Quad Systems AG ("Quad Systems"), with an option to purchase the remaining shares.  Quad Systems is a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-presenting-at-upcoming-conferences-301561474.html

SOURCE Nanalysis Scientific Corp.

FAQ

When is Nanalysis presenting at the LD Micro Conference?

Nanalysis is scheduled to present on June 7, 2022, at 4:30 PM ET.

What is the date and time for Nanalysis at the OTCQX Best 50 Virtual Investor Conference?

Nanalysis will present on June 16, 2022, at 1:00 PM ET.

What opportunities do investors have at the upcoming Nanalysis conferences?

Investors can participate in presentations and schedule 1x1 meetings with Nanalysis management.

How can I access Nanalysis's conference presentations?

Presentations can be accessed through the provided links for each conference.

What is Nanalysis's stock symbol?

Nanalysis trades under the ticker symbols TSXV: NSCI and OTCQX: NSCIF.